AGIO Stock-Based Compensation
Agios Pharmaceuticals Inc · Stock-Based Compensation
AGIO Stock-Based Compensation
Latest reported$57.98Mperiod ending
AGIO TTM Stock-Based Comp ($742.00K → $57.98M)
TTM stock-based compensation
High-resolution chart · PNG
AGIO stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 57,983,000 | |
| 56,734,000 | |
| 52,552,000 | |
| 49,331,000 | |
| 48,099,000 | |
| 44,972,000 | |
| 42,847,000 | |
| 45,758,000 | |
| 43,689,000 | |
| 43,861,000 | |
| 44,766,000 | |
| 42,417,000 | |
| 44,497,000 | |
| 43,925,000 | |
| 49,296,000 | |
| 49,452,000 | |
| 50,444,000 | |
| 54,164,000 | |
| 53,508,000 | |
| 41,887,000 | |
| 29,739,000 | |
| 14,854,000 | |
| 0 | |
| 0 | |
| 18,588,000 | |
| 37,135,000 | |
| 55,243,000 | |
| 73,430,000 | |
| 79,035,000 | |
| 76,943,000 | |
| 73,357,000 | |
| 67,851,000 | |
| 55,865,000 | |
| 51,597,000 | |
| 47,809,000 | |
| 44,968,000 | |
| 44,904,000 | |
| 43,713,000 | |
| 42,086,000 | |
| 41,599,000 | |
| 38,829,000 | |
| 36,010,000 | |
| 31,963,000 | |
| 27,338,000 | |
| 20,857,000 | |
| 15,061,000 | |
| 11,506,000 | |
| 7,943,000 | |
| 6,163,000 | |
| 4,111,000 | |
| 3,030,000 | |
| 2,248,000 | |
| 1,306,000 | |
| 1,068,000 | |
| 742,000 |